8-K
Current Report
MoonLake Immunotherapeutics Filed Acc 0001213900-25-052140
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading ea0245015-8k_moonlake.htm…